Magnesium Controls Cellular Energy and May Slow the Pace of Aging
A new review reframes magnesium as a master regulator of mitochondrial energy, metabolic disease, and biological aging.
Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
294 articles
A new review reframes magnesium as a master regulator of mitochondrial energy, metabolic disease, and biological aging.
A global study of 7,040 cirrhosis inpatients finds CKD present in 18% of cases, dramatically worsening outcomes including AKI and mortality.
UCLA researchers outline best practices for respirometry, the gold-standard method for measuring cellular energy and mitochondrial function.
A real-world study of 15,000+ patients finds tirzepatide outperforms both semaglutide and liraglutide in preventing major cardiac events.
Updated review of anti-obesity medications in MASLD finds GLP-1 agonists reduce steatosis and fibrosis, while newer dual/triple agonists show even greater metabolic promise.
A systematic review of 38 trials finds tirzepatide cuts HbA1c nearly 3x more than lixisenatide with similar GI side effect rates.
A completed University of Michigan trial explored how aerobic exercise training alters RAGE-mediated inflammatory pathways in type 2 diabetic adults.
A new ESRRA-ATG5 axis links mitochondrial recycling to arginine metabolism, and a plant polyphenol activates it to protect diabetic kidneys.
Knocking out BNIP3 in macrophages reduced adipose inflammation and improved insulin sensitivity in obese mice, revealing a new therapeutic target.
A 10-year MRI follow-up of two RCTs finds visceral fat reduction — not weight loss — drives lasting cardiometabolic protection.
New evidence reveals mitochondria form functionally distinct subpopulations within tissues and even single cells, reshaping how we understand energy metabolism.
New review reveals GLP-1 receptor agonists may directly suppress chronic inflammation across multiple organ systems, far beyond their metabolic benefits.